Skip to main content

Table 3 Adverse reactions

From: The efficacy and safety of a taxane-based chemotherapy regimen combined with a PD-1 inhibitor in HNSCC: a multicenter real-world study

Adverse Reaction Types

Severity Levels

All Grades, n (%)

Grade 3/4, n (%)

1

2

3

4

n

%

n

%

Anemia

53

33

9

2

97

62.99

11

7.14

Leukopenia

27

25

8

7

64

43.51

15

9.74

Neutropenia

9

13

6

5

33

21.43

11

7.14

Thrombocytopenia

19

6

1

2

28

18.18

3

1.95

Elevated Transaminases

44

2

0

0

46

29.87

0

0.00

Hypothyroidism

45

1

0

0

46

29.87

0

0.00

Bullous Dermatitis

0

0

0

1

1

0.65

1

0.65